Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
The underlying circuit imbalance in major depression remains unknown and current therapies remain inadequate for a large group of patients. Discovery of the rapid antidepressant effects of ketamine--an NMDA receptor (NMDAR) antagonist--has linked the glutamatergic system to depression. Interestingly, dysfunction in the inhibitory GABAergic system has also been proposed to underlie depression and deficits linked to GABAergic neurons have been found with human imaging and in post-mortem material from depressed patients. Parvalbumin-expressing (PV) GABAergic interneurons regulate local circuit function through perisomatic inhibition and their activity is NMDAR-dependent, providing a possible link between NMDAR and the inhibitory system in the antidepressant effect of ketamine. We have therefore investigated the role of the NMDAR-dependent activity of PV interneurons for the development of depression-like behavior as well as for the response to rapid antidepressant effects of NMDAR antagonists. We used mutant mice lacking NMDA neurotransmission specifically in PV neurons (PV-Cre+/NR1f/f) and analyzed depression-like behavior and anhedonia. To study the acute and sustained effects of a single NMDAR antagonist administration, we established a behavioral paradigm of repeated exposure to forced swimming test (FST). We did not observe altered behavioral responses in the repeated FST or in a sucrose preference test in mutant mice. In addition, the behavioral response to administration of NMDAR antagonists was not significantly altered in mutant PV-Cre+/NR1f/f mice. Our results show that NMDA-dependent neurotransmission in PV neurons is not necessary to regulate depression-like behaviors, and in addition that NMDARs on PV neurons are not a direct target for the NMDAR-induced antidepressant effects of ketamine and MK801.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“ketamine did not alter immobility or swimming during the forced swim test 30 minutes, 24 hours, or one-week post-treatment in PVCreGluN1 mice relative to GluN1f/f mice which suggests that the antidepressant-like effects of ketamine require GluN1 in PV interneurons.”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Pozzi et al., 2014
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“saline treated PVCreGluN1 and GluN1f/f mice appear to have a 2- to 3-fold higher immobility and lower swimming time relative to C57BL/6N WT which suggests that the GluN1f/f mutation was alone sufficient to impact the FST.”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Pozzi et al., 2014
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ketamine (3 mg/kg) reduced immobility and increased swimming behavior in wild-type (WT) mice 30 minutes and 24 hours post-treatment.”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Pozzi et al., 2014
The cited source says what the claim attributes to it.
In the citing paper
“Specifically, loss of the GluN1 subunit of the NMDA receptors on parvalbumin expressing GABAergic interneurons did not alter the behavioral response to ketamine, suggesting that NMDA receptors on parvalbumin containing interneurons are not the target for ketamine's antidepressant effects (Pozzi et al., 2014).”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Pozzi et al., 2014
In the citing paper
“In addition, mice lacking NMDAR (GluN1) in parvalbumin-expressing interneurons, designed to mimic disinhibition of pyramidal cell activity, retained ketamine-induced antidepressant activity 57.”
From Mechanisms of ketamine action as an antidepressant (2018) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451 · cited 1×
“forced swimming test, FST) to score the antidepressant-like effects [37] of the non-competitive glutamate NMDAR antagonists ketamine and MK801 using doses and routes of administration of ketamine and MK801 previously”
MethodTrivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · cited 1×
“It is now well recognized that in addition to ketamine and MK801 [4], [9], [12,13] various NMDAR antagonists such as amantadine and memantine can exhibit antidepressant activity in patients and in a range of preclinical screening procedures (reviewed in [14]).”
BackgroundA randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766 · cited 1×
“It is now well recognized that in addition to ketamine and MK801 [4], [9], [12,13] various NMDAR antagonists such as amantadine and memantine can exhibit antidepressant activity in patients and in a range of preclinical screening procedures (reviewed in [14]).”
BackgroundParvalbumin neurons and gamma rhythms enhance cortical circuit performance
Sohal, V. S., Zhang, F., Yizhar, O., & Deisseroth, K. (2009) · Nature · doi:10.1038/nature07991 · Cited by 2,606 · cited 1×
“Of the inhibitory neurons, fast-spiking interneurons expressing the calcium binding protein parvalbumin (PV) have drawn particular interest, with several studies demonstrating their importance in fundamental cortical processes including generation of gamma oscillations [25,26].”
BackgroundDriving fast-spiking cells induces gamma rhythm and controls sensory responses
Cardin, J. A., Carlén, M., Meletis, K., Knoblich, U., Zhang, F., Deisseroth, K., Tsai, L.-H., & Moore, C. I. (2009) · Nature · doi:10.1038/nature08002 · Cited by 2,603 · cited 1×
“The behavioral relevance of the GABAergic system has also been demonstrated, both with pharmacological (reviewed in [21]) and genetic means [22,23] as well as lately with optogenetic tools [24].”
BackgroundSelf-citationNeocortical excitation/inhibition balance in information processing and social dysfunction
Yizhar, O., Fenno, L. E., Prigge, M., Schneider, F., Davidson, T. J., O’Shea, D. J., Sohal, V. S., Goshen, I., Finkelstein, J., Paz, J. T., et al. (2011) · Nature · doi:10.1038/nature10360 · Cited by 2,454 · cited 1×
“Gamma oscillations are tightly linked to cognitive functions [27] and perturbation of PV inhibition disrupts gamma oscillations and impairs cognitive functions [28–30].”
BackgroundNMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 2×
“In rodents, antidepressant-like effects after acute NMDA receptor (NMDAR) antagonist treatment have been observed in many models of depression, including inescapable stress, the forced swimming test, the tail suspension test, learned helplessness models of depression, and exposure to chronic mild stress procedures [3]…”
BackgroundWillner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832 · cited 1×
“Chronic exposure to mild unpredictable stress has been found to reduce the consumption of, and preference for, highly palatable sucrose solution in rodents, a behavior that is reversed by antidepressants [45,46].”
BackgroundMoghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · cited 1×
“In accordance with this theory, acute ketamine administration rapidly increases glutamatergic neurotransmission in the prefrontal cortex of rodents, a process most likely mediated by presynaptic NMDA autoreceptors and/or NMDAR expressed on GABAergic interneurons [40], which are known to shape circuit function by chang…”
BackgroundThe essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory.
Tsien, J. Z., Huerta, P. T., & Tonegawa, S. (1996) · Cell · doi:10.1016/s0092-8674(00)81827-9 · Cited by 1,782
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231 · cited 2×
“A possible mechanism for the antidepressant properties of NMDAR antagonists is the disinhibition of glutamatergic neurons of the medial prefrontal cortex (mPFC), through a decrease in the activity of PV fast-spiking interneurons [32].”
BackgroundRequirement for Hippocampal CA3 NMDA Receptors in Associative Memory Recall
Nakazawa, K., Quirk, M. C., Chitwood, R. A., Watanabe, M., Yeckel, M. F., Sun, L. D., Kato, A., Carr, C. A., Johnston, D., Wilson, M. A., et al. (2002) · Science · doi:10.1126/science.1071795 · Cited by 1,099 · cited 1×
“Gamma oscillations are tightly linked to cognitive functions [27] and perturbation of PV inhibition disrupts gamma oscillations and impairs cognitive functions [28–30].”
BackgroundA Developmental Switch in the Response of DRG Neurons to ETS Transcription Factor Signaling
Hippenmeyer, S., Vrieseling, E., Sigrist, M., Portmann, T., Laengle, C., Ladle, D. R., & Arber, S. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030159 · Cited by 1,088 · cited 1×
“To generate mice lacking NMDAR specifically in PV interneurons (PVCre/NR1f/f mice) PV-Cre+ mice [38] were crossed to mice carrying ‘floxed’ NR1 alleles [39].”
BackgroundTowards a glutamate hypothesis of depression
Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036 · cited 1×
“The behavioral relevance of the GABAergic system has also been demonstrated, both with pharmacological (reviewed in [21]) and genetic means [22,23] as well as lately with optogenetic tools [24].”
BackgroundTargeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894 · cited 1×
“Recent insights relevant for the development of faster acting antidepressants have come from the discovery that compounds targeting the glutamatergic system have acute antidepressant effects [2].”
BackgroundSubtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y.-T., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796 · cited 2×
“Based on findings in human post-mortem brain material from depressed patients [18–20], it is possible that other types of GABAergic neurons could be of relevance for major depression and for the antidepressant action of ketamine.”
BackgroundMurrough, J. W., Perez, A. M., Pillemer, S., Stern, J., Parides, M. K., aan het Rot, M., Collins, K. A., Mathew, S. J., Charney, D. S., & Iosifescu, D. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.022 · Cited by 786 · cited 1×
“Interestingly, both preclinical animal models and recent clinical trials have reported efficacy of a single administration of the N-methyl-D-aspartate (NMDA) receptor antagonist ketamine on depressive behaviors, with effects that can last for several days [3–6].”
BackgroundFunctional antagonists at the NMDA receptor complex exhibit antidepressant actions
Trullas, R., & Skolnick, P. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90204-j · Cited by 785 · cited 1×
“It is now well recognized that in addition to ketamine and MK801 [4], [9], [12,13] various NMDAR antagonists such as amantadine and memantine can exhibit antidepressant activity in patients and in a range of preclinical screening procedures (reviewed in [14]).”
BackgroundCarlén, M., Meletis, K., Siegle, J. H., Cardin, J. A., Futai, K., Vierling-Claassen, D., Rühlmann, C., Jones, S. R., Deisseroth, K., Sheng, M., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.31 · Cited by 669 · cited 5×
“Genetic deletion of the essential NR1 subunit in PV neurons in PV-Cre+ NR1f/f mice leads to a the functional loss of NMDAR currents, which has previously been demonstrated by whole cell recordings studies in hippocampal slices in vitro, showing that NMDAR-mediated synaptic transmission was abolished in PV interneurons…”
BackgroundMethodSelf-citationThe GABA system in anxiety and depression and its therapeutic potential
Möhler, H. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.040 · Cited by 590 · cited 1×
“The GABAergic system has been proposed to be dysfunctional in mood disorders (reviewed in [15]), and deficiencies in the GABAergic system in patients with major depression have been demonstrated with imaging or in post-”
BackgroundGonzalez-Burgos, G., & Lewis, D. A. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn070 · Cited by 577 · cited 1×
“Gamma oscillations are tightly linked to cognitive functions [27] and perturbation of PV inhibition disrupts gamma oscillations and impairs cognitive functions [28–30].”
BackgroundSanacora, G., Mason, G. F., Rothman, D. L., & Krystal, J. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.663 · Cited by 494 · cited 2×
“Based on findings in human post-mortem brain material from depressed patients [18–20], it is possible that other types of GABAergic neurons could be of relevance for major depression and for the antidepressant action of ketamine.”
BackgroundKorotkova, T., Fuchs, E. C., Ponomarenko, A., von Engelhardt, J., & Monyer, H. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.017 · Cited by 480
Rajkowska, G., O'Dwyer, G., Teleki, Z., Stockmeier, C. A., & Miguel-Hidalgo, J. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301234 · Cited by 430 · cited 2×
“Based on findings in human post-mortem brain material from depressed patients [18–20], it is possible that other types of GABAergic neurons could be of relevance for major depression and for the antidepressant action of ketamine.”
BackgroundJackson, M. E., Homayoun, H., & Moghaddam, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308455101 · Cited by 430 · cited 1×
“In accordance with this theory, acute ketamine administration rapidly increases glutamatergic neurotransmission in the prefrontal cortex of rodents, a process most likely mediated by presynaptic NMDA autoreceptors and/or NMDAR expressed on GABAergic interneurons [40], which are known to shape circuit function by chang…”
BackgroundCognitive Dysfunction in Schizophrenia: Convergence of γ-Aminobutyric Acid and Glutamate Alterations
Lewis, D. A., & Moghaddam, B. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1372 · Cited by 404 · cited 1×
“It has been widely proposed that the GABAergic interneurons, and more specifically the PV interneurons, are a primary target of the non-competitive NMDAR antagonists [31–34].”
BackgroundNeocortical Somatostatin-Expressing GABAergic Interneurons Disinhibit the Thalamorecipient Layer 4
Xu, H., Jeong, H.-Y., Tremblay, R., & Rudy, B. (2013) · Neuron · doi:10.1016/j.neuron.2012.11.004 · Cited by 366
GABA Regulates Excitatory Synapse Formation in the Neocortex via NMDA Receptor Activation
Wang, D. D., & Kriegstein, A. R. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5599-07.2008 · Cited by 299 · cited 1×
“We cannot exclude that GABAergic PV interneurons are relevant to depression through NMDARindependent pathways or by regulating the emotional state in other mood-related disorders The GABAergic system displays great complexity in terms of neuronal subtypes and receptor expression, and controls a number of cognitive and…”
BackgroundBeyond Monoamines: Glutamatergic Function in Mood Disorders
Kugaya, A., & Sanacora, G. (2005) · CNS Spectrums · doi:10.1017/s1092852900010403 · Cited by 290 · cited 1×
“It is now well recognized that in addition to ketamine and MK801 [4], [9], [12,13] various NMDAR antagonists such as amantadine and memantine can exhibit antidepressant activity in patients and in a range of preclinical screening procedures (reviewed in [14]).”
BackgroundBurgdorf, J., Zhang, X.-L., Nicholson, K. L., Balster, R. L., David Leander, J., Stanton, P. K., Gross, A. L., Kroes, R. A., & Moskal, J. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.246 · Cited by 284 · cited 1×
“[43].”
Papp, M., & Moryl, E. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90516-9 · Cited by 272 · cited 1×
“In rodents, antidepressant-like effects after acute NMDA receptor (NMDAR) antagonist treatment have been observed in many models of depression, including inescapable stress, the forced swimming test, the tail suspension test, learned helplessness models of depression, and exposure to chronic mild stress procedures [3]…”
BackgroundEvidence of Cortical Inhibitory Deficits in Major Depressive Disorder
Levinson, A. J., Fitzgerald, P. B., Favalli, G., Blumberger, D. M., Daigle, M., & Daskalakis, Z. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.025 · Cited by 261
Moghaddam, B., & Krystal, J. H. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs075 · Cited by 238 · cited 1×
“It has been widely proposed that the GABAergic interneurons, and more specifically the PV interneurons, are a primary target of the non-competitive NMDAR antagonists [31–34].”
BackgroundMathews, D. C., Henter, I. D., & Zarate, C. A. (2012) · Drugs · doi:10.2165/11633130-000000000-00000 · Cited by 220
GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders
Sibille, E., Morris, H. M., Kota, R. S., & Lewis, D. A. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001616 · Cited by 217 · cited 1×
“mortem material [16–20].”
Anterior Cingulate Cortexγ-Aminobutyric Acid in Depressed Adolescents: Relationship to Anhedonia
Gabbay, V. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.131 · Cited by 201
Jones, R. S. G., & Bühl, E. H. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90341-h · Cited by 174 · cited 1×
“Interestingly, GABAergic PV interneurons express NMDARs and receive a strong NMDA-dependent excitatory input from pyramidal cells [36].”
BackgroundAntidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)
Layer, R. T., Popik, P., Olds, T., & Skolnick, P. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00155-p · Cited by 146 · cited 1×
“In rodents, antidepressant-like effects after acute NMDA receptor (NMDAR) antagonist treatment have been observed in many models of depression, including inescapable stress, the forced swimming test, the tail suspension test, learned helplessness models of depression, and exposure to chronic mild stress procedures [3]…”
BackgroundAntidepressant-like effects of dopamine agonists in an animal model of depression
Muscat, R., Papp, M., & Willner, P. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90119-k · Cited by 130 · cited 1×
“We therefore characterized the response of PV-Cre+/NR1f/f and NR1f/f mice on a standard sucrose preference test, a preclinical measure of anhedonia in rodents [47] (Fig.”
MethodThe rise of a new GABA pharmacology
Möhler, H. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.020 · Cited by 119 · cited 1×
“The behavioral relevance of the GABAergic system has also been demonstrated, both with pharmacological (reviewed in [21]) and genetic means [22,23] as well as lately with optogenetic tools [24].”
BackgroundTargeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders
Machado-Vieira, R., Salvadore, G., Ibrahim, L., Diaz-Granados, N., & Zarate Jr., C. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168010 · Cited by 118 · cited 1×
“This suggests that glutamate NMDAR antagonist-based treatments might represent an effective alternative to current therapies to treat depression [10,11].”
BackgroundMa, X.-C., Dang, Y.-H., Jia, M., Ma, R., Wang, F., Wu, J., Gao, C.-G., & Hashimoto, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056053 · Cited by 114 · cited 1×
“Interestingly, both preclinical animal models and recent clinical trials have reported efficacy of a single administration of the N-methyl-D-aspartate (NMDA) receptor antagonist ketamine on depressive behaviors, with effects that can last for several days [3–6].”
BackgroundVardigan, J. D., Huszar, S. L., McNaughton, C. H., Hutson, P. H., & Uslaner, J. M. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.01.010 · Cited by 85 · cited 2×
“antagonism reduces anhedonic behavior [44].”
BackgroundQuirk, M. C. (2009) · Frontiers in Systems Neuroscience · doi:10.3389/neuro.06.013.2009 · Cited by 75
Goforth, H. W., & Holsinger, T. (2007) · The Journal of ECT · doi:10.1097/01.yct.0000263257.44539.23 · Cited by 63 · cited 1×
“It is now well recognized that in addition to ketamine and MK801 [4], [9], [12,13] various NMDAR antagonists such as amantadine and memantine can exhibit antidepressant activity in patients and in a range of preclinical screening procedures (reviewed in [14]).”
BackgroundMarona-Lewicka, D., & Nichols, D. E. (1997) · Stress · doi:10.3109/10253899709014740 · Cited by 31 · cited 1×
“Chronic exposure to mild unpredictable stress has been found to reduce the consumption of, and preference for, highly palatable sucrose solution in rodents, a behavior that is reversed by antidepressants [45,46].”
BackgroundNowak, K., Meyza, K., Nikolaev, E., Hunt, M., & Kasicki, S. (2012) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2012-1894 · Cited by 21 · cited 1×
“fos protein expression (used as a marker of neuronal activation) in various subcortical regions [42], and systemic administration of MK801 is known to increase the firing of pyramidal neurons of the mPFC of awake rats [42], the direct infusion of ketamine into the mPFC is not sufficient to produce anti-depressant resp…”
Zhou, Z., Zhang, G.-F., Li, X., Yang, C., & Yang, J. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.04.007 · Cited by 9 · cited 2×
“It has been proposed that PV fast-spiking interneurons could play an important role in the antidepressant effects of ketamine [35].”
Background
Cited by
Mechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127
BDNF - a key transducer of antidepressant effects
Björkholm, C., & Monteggia, L. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.034 · Cited by 958
“Specifically, loss of the GluN1 subunit of the NMDA receptors on parvalbumin expressing GABAergic interneurons did not alter the behavioral response to ketamine, suggesting that NMDA receptors on parvalbumin containing interneurons are not the target for ketamine's antidepressant effects (Pozzi et al., 2014).”
BackgroundBrain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action
Castrén, E., & Monteggia, L. M. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.05.008 · Cited by 540
GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions
Gerhard, D. M., Pothula, S., Liu, R.-J., Wu, M., Li, X.-Y., Girgenti, M. J., Taylor, S. R., Duman, C. H., Delpire, E., Picciotto, M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130808 · Cited by 345
“To match the style of Camk2a and GAD67 images, Sst+ and deletion of Grin1 from PvalbCre+ mice did not block the effects of ketamine (44).”
BackgroundAn excitatory synapse hypothesis of depression
Thompson, S. M., Kallarackal, A. J., Kvarta, M. D., Van Dyke, A. M., LeGates, T. A., & Cai, X. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.03.003 · Cited by 265
Metadata
- Authors
- Pozzi, L., Dorocic, I. P., Wang, X., Carlén, M., & Meletis, K.
- Affiliations
- Karolinska Institutet (SE)
- Corresponding author
- Meletis, Konstantinos
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-01-16
- Volume
- 9
- Issue
- 1
- Pages
- e83879
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3894182
- OpenAlex
- W2143999471
- Cited by
- 74
- References
- 49
- Citations by year
- 2026: 2 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 6 · 2020: 8 · 2019: 12 · 2018: 8 · 2017: 4 · 2016: 5 · 2015: 12 · 2014: 5
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-02-28)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- Karolinska Institutet
- Vetenskapsrådet
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- NMDA receptor, parvalbumin interneurons, depression-like behavior, anhedonia, ketamine, rapid antidepressant effects, NMDA receptor antagonists, MK-801, GABAergic inhibition, glutamatergic system, forced swim test, sucrose preference
- MeSH terms
- Animals, Antidepressive Agents, Major Depressive Disorder, Depressive Disorder, Major, Disease Models, Animal, Food Preferences, Humans, Interneurons, Ketamine, Male, Mice, Inbred C57BL, Mice, Transgenic, Motor Activity, Parvalbumins, Swimming, Receptors, N-Methyl-D-Aspartate, Dizocilpine Maleate, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.